SCHEMBL7659849

SCHEMBL7659849

CCCCC(NC(=O)c1cccc(NS(=O)(=O)c2ccc3ccccc3c2)c1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.47
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
WDR5 P61964 1/20 0.44
GGPS1 O95749 1/20 0.44
PLAU P00749 1/20 0.44
GPR27 Q9NS67 1/20 0.43
CA2 P00918 1/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CCKBR P32239 1/20 0.43
KAT6A Q92794 4/20 0.43
AR P10275 1/20 0.42
PHGDH O43175 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658785 0.93 ALDH1A1 (0.45) AKR1C3OPRM1OPRD1WDR5GGPS1
SCHEMBL7665000 0.93 ALDH1A1 (0.52) AKR1C3PLAUGPR27CA2LMNA
SCHEMBL7661487 0.91 EGFR (0.47) OPRM1OPRD1WDR5PLAUCA2
SCHEMBL7680584 0.91 AKR1C3 (0.48) AKR1C3OPRM1OPRD1WDR5GGPS1
SCHEMBL7427436 0.90 AKR1C3 (0.45) AKR1C3WDR5GGPS1PLAUGPR27
SCHEMBL7654043 0.86 ALDH1A1 (0.54) AKR1C3PLAUGPR27CA2LMNA
SCHEMBL7665441 0.85 EGFR (0.46) OPRM1OPRD1WDR5PLAUCA2
SCHEMBL7682470 0.83 ALDH1A1 (0.51) AKR1C3PLAUGPR27CA2LMNA
SCHEMBL7690188 0.83 EGFR (0.48) OPRM1OPRD1WDR5PLAUCA2
SCHEMBL7425669 0.82 ALDH1A1 (0.52) AKR1C3PLAUGPR27CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed